Category: Kaiser Family Foundation

FAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program

The Centers for Medicare & Medicaid Services (CMS) recently issued initial guidance describing CMS’s plans for implementation of the new Medicare Drug Price Negotiation Program, which was established by the Inflation Reduction Act. These FAQs addre…

Understanding the Role of the FTC, DOJ, and States in Challenging Anticompetitive Practices Of Hospitals and Other Health Care Providers

This brief explains the role of federal and state antitrust agencies in challenging anticompetitive practices among hospitals and other health care providers, including the legal authority of federal and state agencies, the role that they play in enfor…

Marketplace Insurers are Proposing a 6% Average Premium Hike for 2024 and Pointing to Inflation as a Key Driver of Costs

ACA Marketplace insurers are requesting a median premium increase of 6% for 2024, according to a new KFF analysis of the preliminary rate filings. Insurers’ proposed rate changes – most of which fall between 2% and 10% – may change during the review pr…

An Early Look at What is Driving Health Costs in 2024 ACA Markets

In their early rate filings, Marketplace insurers are requesting a median premium increase of 6% for 2024, which they say is largely due to price increases for medical care and prescription drugs.

An Early Look at What is Driving Health Costs in 2024 ACA Markets

In their early rate filings, Marketplace insurers are requesting a median premium increase of 6% for 2024, which they say is largely due to price increases for medical care and prescription drugs.

How much and why 2024 premiums are expected to grow in Affordable Care Act Marketplaces

This analysis of insurers’ preliminary rate filings shows that ACA Marketplace insurers are requesting a median premium increase of 6% for 2024. Insurers cite price increases for medical care and prescription drugs as a key driver of premium growth in …

KFF Health Tracking Poll July 2023: The Public’s Views Of New Prescription Weight Loss Drugs And Prescription Drug Costs

About half of adults are interested in taking prescription weight loss drugs. though interest drops when presented with obstacles or drawbacks. Many adults struggle with affording prescription drugs and say there should be more price regulation. Few ar…

Poll: Nearly Half of Adults Would Be Interested in Prescription Weight-Loss Drugs, But Enthusiasm Fades Based on Lack of Coverage and Risk of Regaining Weight 

Nearly half (45%) of the public are at least somewhat interested in taking a prescription weight-loss drug, including many who say they only want to lose a little weight, though many people lose interest when presented with potential financial and medi…

How Does Medical Inflation Compare to Inflation in the Rest of the Economy?

Prices for medical services typically rise more quickly than the broader economy, but the reverse has been true recently as general inflation rose rapidly. This analysis finds that overall prices grew by 6% in February 2023 from the previous year, whil…

How has Health Care Employment Changed Since the Pandemic?

This chart collection takes a deep dive into employment data to analyze how health sector jobs and wages shrank and recovered since the coronavirus pandemic struck in early 2020.